The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Symptomatic Toxicities Experienced During Anticancer Treatment: Agreement Between Patient and Physician Reporting in Three Randomized Trials
Open accessAbstract
Purpose: Information about symptomatic toxicities of anticancer treatments is not based on direct report by patients, but rather on reports by clinicians in trials. Given the potential for under-reporting, our aim was to compare reporting by patients and physicians of six toxicities (anorexia, nausea, vomiting, constipation, diarrhea, and hair loss) within three randomized trials. Patients and Methods: In one trial, elderly patients with breast cancer received adjuvant chemotherapy; in two trials, patients with advanced non–small-cell lung cancer received first-line treatment. Toxicity was prospectively collected by investigators (graded by National Cancer Institute Common Toxicity Criteria [version 2.0] or Common Terminology Criteria for Adverse Events [version 3]). At the end of each cycle, patients completed the European Organisation for Research and Treatment of Cancer quality-of-life questionnaires, including toxicity-related symptom items. Possible answers were “not at all,” “a little,” “quite a bit,” and “very much.” Analysis was limited to the first three cycles. For each toxicity, agreement between patients and physicians and under-reporting by physicians (ie, toxicity reported by patients but not reported by physicians) were calculated. Results: Overall, 1,090 patients (2,482 cycles) were included. Agreement between patients and physicians was low for all toxicities. Toxicity rates reported by physicians were always lower than those reported by patients. For patients who reported toxicity (any severity), under-reporting by physicians ranged from 40.7% to 74.4%. Examining only patients who reported “very much” toxicity, under-reporting by physicians ranged from 13.0% to 50.0%. Conclusion: Subjective toxicities are at high risk of under-reporting by physicians, even when prospectively collected within randomized trials. This strongly supports the incorporation of patient-reported outcomes into toxicity reporting in clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“However, several randomized clinical trials with similar interventions have proven that RPM significantly improves symptom burden in comparison with routine care.7,13,14”
From Implementation of a remote symptom monitoring pathway in oncology care: analysis of real-world experience across 33 cancer centres in France and Belgium (2024) · cites this paper as [7]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Coefficient of Agreement for Nominal Scales
Cohen, J. (1960) · Educational and Psychological Measurement · doi:10.1177/001316446002000104 · Cited by 42,398
Statistical Methods for Rates and Proportions
Fleiss, J. L., Levin, B., & Paik, M. C. (2003) · Wiley Series in Probability and Statistics · doi:10.1002/0471445428 · Cited by 18,646
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., Haes, J. C. J. M. D., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.5.365 · Cited by 16,005
Toutenburg, H. (1974) · Biometrische Zeitschrift · doi:10.1002/bimj.19740160814 · Cited by 1,547
Sprangers, M. A., Groenvold, M., Arraras, J. I., Franklin, J., te Velde, A., Muller, M., Franzini, L., Williams, A., de Haes, H. C., Hopwood, P., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.10.2756 · Cited by 1,220
Bergman, B., Aaronson, N. K., Ahmedzai, S. H., Kaasa, S., & Sullivan, M. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(94)90535-5 · Cited by 906
Basch, E., Iasonos, A., McDonough, T., Barz, A., Culkin, A., Kris, M. G., Scher, H. I., & Schrag, D. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70910-x · Cited by 653
Fromme, E. K., Eilers, K. M., Mori, M., Hsieh, Y.-C., & Beer, T. M. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.03.025 · Cited by 555
Physicians' and patients' choices in evidence based practice
Haynes, R. B., Devereaux, P. J., & Guyatt, G. H. (2002) · BMJ · doi:10.1136/bmj.324.7350.1350 · Cited by 534
Correlation of patient and caregiver ratings of cancer pain
Grossman, S. A., Sheidler, V. R., Swedeen, K., Mucenski, J. W., & Piantadosi, S. (1991) · Journal of Pain and Symptom Management · doi:10.1016/0885-3924(91)90518-9 · Cited by 434
(1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.2.671 · Cited by 430
Patient-Reported Outcomes and the Evolution of Adverse Event Reporting in Oncology
Trotti, A., Colevas, A. D., Setser, A., & Basch, E. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.4784 · Cited by 331
Gridelli, C., Ciardiello, F., Gallo, C., Feld, R. D., Butts, C. A., Gebbia, V., Maione, P., Morgillo, F., Genestreti, G., Favaretto, A. G., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.41.2056 · Cited by 236
Self-citationGridelli, C., Gallo, C., Ceribelli, A., Gebbia, V., Gamucci, T., Ciardiello, F., Carozza, F., Favaretto, A. G., Daniele, B., Galetta, D., et al. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70146-8 · Cited by 169
Self-citationBasch, E. (2013) · Annual Review of Medicine · doi:10.1146/annurev-med-010713-141500 · Cited by 139
Petersen, M. A., Larsen, H., Pedersen, L., Sonne, N. M., & Grøenvold, M. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.032 · Cited by 132
Cirillo, M., Venturini, M., Ciccarelli, L., Coati, F., Bortolami, O., & Verlato, G. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp287 · Cited by 124
Basch, E., Bennett, A. V., & Pietanza, M. C. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr493 · Cited by 110
Bruner, D. W., Hanisch, L. J., Reeve, B. B., Trotti, A., Schrag, D., Sit, L., Mendoza, T. R., Minasian, L. M., O’Mara, A. M., Denicoff, A. M., et al. (2011) · Translational Behavioral Medicine · doi:10.1007/s13142-011-0025-3 · Cited by 88
Gravis, G., Marino, P., Joly, F., Oudard, S. M., Priou, F., Esterni, B., Latorzeff, I., Delva, R., Krakowski, I., Laguerre, B., et al. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2013.11.034 · Cited by 69
Electronic Toxicity Monitoring and Patient-Reported Outcomes
Basch, E., Reeve, B. B., Mitchell, S. A., Clauser, S. B., Minasian, L. M., Sit, L., Chilukuri, R., Baumgartner, P., Rogak, L. J., Blauel, E. R., et al. (2011) · The Cancer Journal · doi:10.1097/ppo.0b013e31822c28b3 · Cited by 56
Nuzzo, F., Morabito, A., Maio, E. D., Rella, F. D., Gravina, A., Labonia, V., Landi, G., Pacilio, C., Piccirillo, M. C., Rossi, E., et al. (2007) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2007.10.006 · Cited by 26
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Dueck, A. C., Mendoza, T. R., Mitchell, S. A., Reeve, B. B., Castro, K. M., Rogak, L. J., Atkinson, T. M., Bennett, A. V., Denicoff, A. M., O'Mara, A. M., et al. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.2639 · Cited by 1,030
de Boer, S. M., Powell, M. E. B., Mileshkin, L., Katsaros, D., Bessette, P., Haie-Méder, C., Ottevanger, P. B., Ledermann, J. A., Khaw, P., Colombo, A., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30079-2 · Cited by 646
Pearce, A. M., Haas, M. R., Viney, R. C., Pearson, S., Haywood, P., Brown, C. S. B., & Ward, R. L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184360 · Cited by 542
Di Maio, M., Basch, E., Denis, F., Fallowfield, L. J., Ganz, P. A., Howell, D., Kowalski, C., Perrone, F., Stover, A. M., Sundaresan, P., et al. (2022) · Annals of Oncology · doi:10.1016/j.annonc.2022.04.007 · Cited by 509
Self-citationAntiemetic Prophylaxis for Chemotherapy-Induced Nausea and Vomiting
Navari, R. M., & Aapro, M. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1515442 · Cited by 479
Metadata
- Authors
- Di Maio, M., Gallo, C., Leighl, N. B., Piccirillo, M. C., Daniele, G., Nuzzo, F., Gridelli, C., Gebbia, V., Ciardiello, F., De Placido, S., Ceribelli, A., Favaretto, A. G., de Matteis, A., Feld, R., Butts, C., Bryce, J., Signoriello, S., Morabito, A., Rocco, G., & Perrone, F.
- Affiliations
- Massimo Di Maio, Maria Carmela Piccirillo, Gennaro Daniele, Francesco Nuzzo, Andrea de Matteis, Jane Bryce, Alessandro Morabito, Gaetano Rocco, and Francesco Perrone, Istituto Nazionale Tumori–Fondazione “G. Pascale” Istituto di Ricovero e Cura a Carattere Scientifico; Ciro Gallo, Fortunato Ciardiello, and Simona Signoriello, Second University; Sabino De Placido, Federico II University, Napoli; Cesare Gridelli, S.G. Moscati Hospital, Avellino; Vittorio Gebbia, Istituto La Maddalena, Palermo; Anna...
- Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" (IT)
- ORCID
- Venue
- Journal of Clinical Oncology
- Published
- 2015-03-10
- Volume
- 33
- Issue
- 8
- Pages
- 910-915
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2156635540
- Cited by
- 497
- References
- 22
- Citations by year
- 2026: 33 · 2025: 40 · 2024: 51 · 2023: 42 · 2022: 50 · 2021: 51 · 2020: 49 · 2019: 42 · 2018: 40 · 2017: 38 · 2016: 38 · 2015: 22
- FWCI
- 20.09
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Oncology (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion, other-oa)
- Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Health Sciences › Medicine › Oncology › Cancer Treatment and Pharmacology
- Keywords
- anticancer treatment, patient-physician agreement, underreporting, patient-reported outcomes, anorexia, nausea and vomiting, constipation, diarrhea, hair loss, adjuvant chemotherapy, breast cancer, non-small cell lung cancer, first-line therapy
- MeSH terms
- Adult, Aged, Aged, 80 and over, Anorexia, Antineoplastic Agents, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Constipation, Diarrhea, Europe, Female, Humans, Hypotrichosis, Lung Neoplasms, Male, Middle Aged, Nausea, Patient Participation, Physicians, Prospective Studies, Quality of Life, Surveys and Questionnaires, Vomiting, Reproducibility of Results, Treatment Outcome, Chemotherapy, Adjuvant
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
